Last 12 months
Inside the activity.
0 purchase rows · 204 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 26 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 32 |
| Jul 2026 | 0 | 64 |
| Aug 2026 | 0 | 27 |
| Sep 2026 | 0 | 20 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2019 Filed Nov 21, 2019 00:19 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 19,500 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-19-000118 · wf-form4_157429554336283.xml · derivative · entry 8 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597,575 Underlying: Ordinary Shares · 19,500 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:19 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 100 | $198.93 | $19,893.00 |
DisclosureSEC source: 0001651308-19-000118 · wf-form4_157429554336283.xml · nonDerivative · entry 7 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:19 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 95 | $195.82 | $18,602.90 |
DisclosureSEC source: 0001651308-19-000118 · wf-form4_157429554336283.xml · nonDerivative · entry 6 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:19 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 605 | $195.01 | $117,983.35 |
DisclosureSEC source: 0001651308-19-000118 · wf-form4_157429554336283.xml · nonDerivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.53 to $195.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:19 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 500 | $193.63 | $96,813.00 |
DisclosureSEC source: 0001651308-19-000118 · wf-form4_157429554336283.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.31 to $193.85, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:19 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 200 | $192.24 | $38,448.00 |
DisclosureSEC source: 0001651308-19-000118 · wf-form4_157429554336283.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.90 to $192.58, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:19 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 1,500 | $29.49 | $44,235.00 |
DisclosureSEC source: 0001651308-19-000118 · wf-form4_157429554336283.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 325,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · derivative · entry 11 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,795,000 Underlying: Ordinary Shares · 325,000 shares Expires 2025-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F10 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 400 | $198.93 | $79,572.00 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 10 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 200 | $197.55 | $39,510.00 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 9 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 200 | $196.63 | $39,326.00 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 8 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.22 to $197.04, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 5,633 | $195.57 | $1,101,671.16 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 7 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.14 to $196.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 8,156 | $194.62 | $1,587,310.93 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 6 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,433 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.13 to $195.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 6,944 | $193.60 | $1,344,334.10 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 5 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,589 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.12 to $194.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 2,311 | $192.63 | $445,168.16 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 4 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,533 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.12 to $193.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
SaleAmerican Depositary Shares | 1,156 | $191.80 | $221,723.69 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 3 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,844 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.09 to $192.03, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:20 UTC |
Liang HowardCFO & Chief Strategy Officer
|
Exercise / conversionAmerican Depositary Shares | 25,000 | $6.50 | $162,500.00 |
DisclosureSEC source: 0001651308-19-000119 · wf-form4_157429562436934.xml · nonDerivative · entry 2 Liang Howard · CIK 0001663427 · CFO & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:22 UTC |
Wu XiaobinPresident & GM China
|
SaleAmerican Depositary Shares | 1,000 | $202.05 | $202,050.00 |
DisclosureSEC source: 0001651308-19-000116 · wf-form4_157411574054527.xml · nonDerivative · entry 3 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2018. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 395 | $202.05 | $79,809.75 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 14 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F3 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 1,496 | $202.05 | $302,266.80 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 12 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 2,605 | $193.57 | $504,241.77 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 13 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 395 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F3 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 100 | $196.87 | $19,687.00 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 11 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,496 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 300 | $195.86 | $58,757.01 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 10 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,596 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.80 to $195.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 1,900 | $195.14 | $370,773.98 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 9 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,896 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.74 to $195.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 704 | $194.12 | $136,662.17 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 8 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,796 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.74 to 194.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 2,200 | $193.04 | $424,691.52 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 7 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.67 to $193.41, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 2,500 | $192.19 | $480,482.25 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 6 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,700 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.64 to $192.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 800 | $191.03 | $152,826.00 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 5 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,200 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.50 to $191.42, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 13, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
GrantOrdinary Shares | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 4 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 50 F4 · ownership.nature: These securities are held by the spouse of the Reporting Person. Read SEC document |
| November 13, 2019 Filed Nov 18, 2019 22:24 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
OtherOrdinary Shares | 50 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-19-000117 · wf-form4_157411585017840.xml · nonDerivative · entry 3 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,903,998 F2 · kind: Pro rata distribution for no value from Wang Investment LLC which is exempt pursuant to Rule 16a-13 and Rule 16a-9. F3 · ownership.nature: These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 52,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · derivative · entry 13 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,988 Underlying: Ordinary Shares · 52,000 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F12 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board or otherwise ceases to serve as a director, unless the Board determines otherwise. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 208 | $190.32 | $39,587.18 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 10 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.15 to $190.9450, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 1,892 | $189.56 | $358,639.76 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 9 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.07 to $190.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 1,500 | $188.71 | $283,069.80 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 8 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.07 to $189.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 200 | $187.38 | $37,475.56 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 7 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.89 to $187.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
Exercise / conversionAmerican Depositary Shares | 4,000 | $41.01 | $164,040.00 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 6 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 21:22 UTC |
Wang XiaodongDirector · Chair, Scientific Advisory Brd
|
SaleAmerican Depositary Shares | 1,000 | $190.00 | $190,000.00 |
DisclosureSEC source: 0001651308-19-000103 · wf-form4_157298891097486.xml · nonDerivative · entry 5 Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:51 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 427,700 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-19-000105 · wf-form4_157308428568415.xml · derivative · entry 8 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617,075 Underlying: Ordinary Shares · 427,700 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F9 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:51 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 300 | $192.77 | $57,831.00 |
DisclosureSEC source: 0001651308-19-000105 · wf-form4_157308428568415.xml · nonDerivative · entry 7 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.65 to $192.88, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:51 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 2,854 | $191.96 | $547,844.42 |
DisclosureSEC source: 0001651308-19-000105 · wf-form4_157308428568415.xml · nonDerivative · entry 6 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.53 to $192.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:51 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 12,654 | $191.01 | $2,417,011.44 |
DisclosureSEC source: 0001651308-19-000105 · wf-form4_157308428568415.xml · nonDerivative · entry 5 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,154 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.47 to $191.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:51 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 12,523 | $190.00 | $2,379,398.80 |
DisclosureSEC source: 0001651308-19-000105 · wf-form4_157308428568415.xml · nonDerivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,808 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.46 to $190.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:51 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 4,569 | $189.08 | $863,921.14 |
DisclosureSEC source: 0001651308-19-000105 · wf-form4_157308428568415.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,331 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.46 to $189.45, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 23:51 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 32,900 | $29.49 | $970,221.00 |
DisclosureSEC source: 0001651308-19-000105 · wf-form4_157308428568415.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 52,000 | $0.00 Strike: $3.16 | $0.00 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · derivative · entry 12 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,988 Underlying: Ordinary Shares · 52,000 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F12 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board or otherwise ceases to serve as a director, unless the Board determines otherwise. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 200 | $192.06 | $38,411.26 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 11 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.42 to $192.40, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 100 | $192.18 | $19,218.00 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 5 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 1,306 | $191.32 | $249,861.96 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 4 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.97 to $191.93, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 1,394 | $190.34 | $265,337.72 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 3 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,406 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.95 to $190.87, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 18:50 UTC |
Chen Timothy Yung-ChengDirector
|
SaleAmerican Depositary Shares | 1,200 | $189.37 | $227,243.64 |
DisclosureSEC source: 0001651308-19-000104 · wf-form4_157308420560017.xml · nonDerivative · entry 2 Chen Timothy Yung-Cheng · CIK 0001374068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.92 to $189.89, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.